Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$895M |
| 2 |
Analog Devices
ADI
|
+$737M |
| 3 |
Zai Lab
ZLAB
|
+$472M |
| 4 |
NetEase
NTES
|
+$465M |
| 5 |
Cisco
CSCO
|
+$440M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.48B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$898M |
| 3 |
Procter & Gamble
PG
|
+$567M |
| 4 |
Oracle
ORCL
|
+$478M |
| 5 |
Capital One
COF
|
+$459M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 12.62% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNFT
3801
DELISTED
Benefitfocus, Inc.
BNFT
| $120K | ﹤0.01% |
+10,843
| New | +$132K |
|
3802
Cytosorbents Corp
CTSO
$23.7M
| $119K | ﹤0.01% |
14,645
+3,601
| +33% | +$29.3K |
|
|
AKUS
3803
DELISTED
Akouos Inc
AKUS
| $118K | ﹤0.01% |
+10,073
| New | +$121K |
|
|
ATHX
3804
DELISTED
Athersys, Inc. Common Stock
ATHX
| $118K | ﹤0.01% |
3,544
+683
| +24% | +$25.9K |
|
3805
NextCure
NXTC
$23.5M
| $117K | ﹤0.01% |
1,453
+19
| +1% | +$1.67K |
|
3806
Spyre Therapeutics
SYRE
$9.11B
| $117K | ﹤0.01% |
589
+67
| +13% | +$11.7K |
|
3807
CuriosityStream
CURI
$156M
| $116K | ﹤0.01% |
+11,012
| New | +$130K |
|
|
NNDM
3808
Nano Dimension
NNDM
$333M
| $116K | ﹤0.01% |
20,645
| – | – |
|
3809
Neurogene
NGNE
$686M
| $115K | ﹤0.01% |
792
+88
| +13% | +$13.5K |
|
|
SIEN
3810
DELISTED
Sientra, Inc.
SIEN
| $115K | ﹤0.01% |
2,011
+477
| +31% | +$32.6K |
|
|
ATNX
3811
DELISTED
Athenex, Inc. Common Stock
ATNX
| $115K | ﹤0.01% |
1,922
+309
| +19% | +$22.5K |
|
3812
Mammoth Energy Services
TUSK
$137M
| $114K | ﹤0.01% |
39,067
+1,364
| +4% | +$4.86K |
|
|
TCRR
3813
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $114K | ﹤0.01% |
13,419
+1,199
| +10% | +$16.9K |
|
|
HGEN
3814
DELISTED
HUMANIGEN, INC.
HGEN
| $113K | ﹤0.01% |
18,977
+4,024
| +27% | +$56.5K |
|
|
LONA
3815
LeonaBio Inc
LONA
$72M
| $112K | ﹤0.01% |
+1,194
| New | +$122K |
|
3816
YPF
YPF
$19.5B
| $111K | ﹤0.01% |
23,855
+996
| +4% | +$4.66K |
|
3817
Cardiff Oncology
CRDF
$72.3M
| $110K | ﹤0.01% |
16,421
+3,436
| +26% | +$21.6K |
|
3818
Citius Pharmaceuticals
CTXR
$17.1M
| $110K | ﹤0.01% |
2,183
+435
| +25% | +$21.8K |
|
|
KZR
3819
DELISTED
Kezar Life Sciences
KZR
| $110K | ﹤0.01% |
1,275
+137
| +12% | +$9.07K |
|
|
MTEM
3820
DELISTED
Molecular Templates, Inc.
MTEM
| $109K | ﹤0.01% |
1,083
+218
| +25% | +$22.5K |
|
3821
Puma Biotechnology
PBYI
$397M
| $108K | ﹤0.01% |
15,370
+2,545
| +20% | +$19.1K |
|
3822
Abits Group
ABTS
$3.73M
| $107K | ﹤0.01% |
+904
| New | +$177K |
|
|
ASRT
3823
DELISTED
Assertio
ASRT
| $107K | ﹤0.01% |
7,889
+276
| +4% | +$4.72K |
|
|
LITS
3824
Lite Strategy Inc
LITS
$32.1M
| $106K | ﹤0.01% |
1,925
+473
| +33% | +$26K |
|
3825
Citizens
CIA
$235M
| $105K | ﹤0.01% |
16,981
+2,504
| +17% | +$14.2K |
|
Similar funds
Invesco's Q3 2021 Portfolio in Review
As of Q3 2021, Invesco held 4,110 positions worth $395B, down 2.9% from $407B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Invesco's Q3 2021 filing shows 151 new, 2,106 increased, 1,588 reduced and 95 closed positions. Its largest new stake was GXO Logistics: 973,368 shares worth $76.4M. The largest sale was Alibaba, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Invesco's largest Q3 2021 buy was GXO Logistics: 973,368 shares worth $76.4M.
- Invesco added most to Salesforce in Q3 2021, an estimated $895M increase.
- Invesco's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.48B.
- Invesco fully exited Maxim Integrated Products in Q3 2021, selling an estimated $898M.
- Invesco's ten largest holdings make up 11% of its $395B portfolio in Q3 2021.
- Invesco opened 151 new positions and closed 95 in Q3 2021.
- Invesco's portfolio value fell 2.9% quarter-over-quarter to $395B.
Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.